Products
Gacovetug Biosimilar VH-Fc Antibody (F4+ ETEC) for Research
Cat No.: GMP-Bios-INN-1211
Anti-F4+ ETEC (Veterinary Application) therapeutic antibody (Pre-made Gacovetug biosimilar,Dimerised heavy domain (VH-h-CH2-CH3-CHS dimer)) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Gacovetug is a heavy-chain domain antibody. It is developed by Vrije Universiteit Brussel for Veterinary F4+ E coli Infections.
Order Information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-1211-1mg | 1mg | 3090 |
| GMP-Bios-INN-1211-10mg | 10mg | |
| GMP-Bios-INN-1211-100mg | 100mg | |
| GMP-Bios-INN-1211-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Gacovetug biosimilar, Dimerised heavy domain (VH-h-CH2-CH3-CHS dimer): Anti-F4+ ETEC (Veterinary Application) therapeutic antibody |
| INN Name | Gacovetug |
| Target | F4+ ETEC (Veterinary Application) |
| Format | Dimerised heavy domain (VH-h-CH2-CH3-CHS dimer) |
| Derivation | na |
| Species Reactivity | Human |
| CH1+2+3 Isotype | A1 |
| VD LC | na |
| Highest_Clin_Trial (Jan '20) | TBC |
| Est. Status | Active |
| 100% SI Structure | 4wen:B |
| 99% SI Structure | None |
| 95-98% SI Structure | None |
| Year Proposed | 2024 |
| Year Recommended | na |
| Companies | Vrije Universiteit Brussel |
| Conditions Approved | na |
| Conditions Active | Veterinary F4+ E coli Infections |
| Conditions Discontinued | na |
| Production | na |
| Development Tech | na |
